Research: Virus delays progression of pediatric tumors

02/17/2008 | Washington Post, The

A new study revealed that a laboratory-engineered virus known as rQT3 delayed the development of neuroblastoma and peripheral nerve sheath tumors without damaging healthy tissues and prolonged the life span of diseased mice. Researchers created the viral therapy by equipping the oncolytic herpes simplex virus with a gene that inhibits enzymes responsible for the growth of certain tumors.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR